Factors associated with significant liver fibrosis assessed using transient elastography in general population

Table 1 Baseline characteristics of study population (n = 159)

Variables	Values
Demographic variables
Age, yr	56.0 ± 10.6
Male gender	87 (54.7)
Body mass index, kg/m2	24.3 ± 3.1
Diabetes mellitus	19 (11.9)
Hypertension	40 (25.2)
Daily alcohol intake, mg	15.4 ± 30.5
Laboratory variables
Aspartate aminotransferase, IU/L	23.3 ± 8.5
Alanine aminotransferase, IU/L	23.1 ± 12.2
Platelet count, 109/L	235.5 ± 57.9
Fasting plasma glucose, mg/dL	100.5 ± 24.5
HOMA-IR	1.84 ± 1.35
HbA1c, %	6.0 ± 0.7
Imaging variables
Severe fatty liver on sonography	30 (18.9)
Carotid sonography
Intimal media thickness, mm	0.75 ± 0.57
Presence of carotid plaque	34 (21.4)
Calcified carotid plaque, n	0.48 ± 1.13
Computed tomography
Visceral fat area, cm2	112.4 ± 54.8
Transient elastography
Controlled attenuation parameter, dB/m	248.3 ± 44.4
Interquartile rangeCAP, dB/m	35.91 ± 13.56
Interquartile range/medianCAP	0.16 ± 0.06
Liver stiffness value, kPa	4.7 ± 2.2
Interquartile rangeLS, kPa	0.52 ± 0.21
Interquartile range/medianLS	0.13 ± 0.06

Values are expressed as the mean ± SD (range) or n (%). HOMA-IR: Homeostasis model assessment of insulin resistance; HbA1c: Glycated hemoglobin; CAP: Controlled attenuation parameter; LS: Liver stiffness.